"The main goal of early phase trials is to gain knowledge about the clinical suitability of novel compounds, without pursuing specific therapeutic purposes. Healthy volunteers usually represent the ideal model for conducting phase I clinical trials, in order to investigate pharmacokinetics and pharmacodynamics as well as to document safety and tolerability without interference by concomitant pathological conditions."
- Forums
- ASX - By Stock
- NSB
- Ann: Ethics Approval Granted for Early-Phase Clinical Trial
Ann: Ethics Approval Granted for Early-Phase Clinical Trial, page-27
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NSB (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.494M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 357123 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 199999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 357123 | 0.038 |
2 | 225000 | 0.036 |
1 | 200000 | 0.035 |
2 | 249400 | 0.034 |
2 | 130000 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 199999 | 1 |
0.042 | 29703 | 2 |
0.046 | 334000 | 1 |
0.048 | 279261 | 1 |
0.050 | 201085 | 2 |
Last trade - 10.13am 15/08/2024 (20 minute delay) ? |
Featured News
NSB (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online